Dr. Aditya Chand Mehra, MD

Dr. Mehra practices at Seashore Surgical Institute in Brick, New Jersey.

Dr. Mehra's NPI, 1922274141, was assigned on May 7, 2008. Dr. Mehra holds New Jersey license 25MA08361400.

Dr. Mehra's primary practice is Seashore Surgical Institute, at 495 Jack Martin Boulevard, Brick, NJ 08724. The practice phone is (732) 836-9800.

Dr. Mehra's primary practice is Seashore Surgical Institute in Brick, New Jersey. Dr. Mehra is also affiliated with Ocean University Medical Center. The medical group on file is Meridian Cardiovascular Interpretive Services. Dmand AI also links Dr. Mehra to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehra practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mehra's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mehra is licensed in New Jersey.

CMS data shows 12,277 Medicare services from Dr. Mehra across 53 procedure codes in 2024, for 2,505 Medicare patients. Medicare paid $1,158,423 for them.

CMS counts 2,505 Medicare patients who saw Dr. Mehra in 2024. The largest group is 75 to 84, with 956 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehra's median patient age at 69, with 49% women.

In 2024, Dr. Mehra wrote 5,867 Medicare Part D claims for 715 patients. 87% of them were for generic drugs. CMS names the drug for 5,539 of them, across 59 drugs with 11 or more claims each, at $878,335 in total drug cost. In 2023, CMS named 5,157 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 21 out of 100 for Dr. Mehra for performance year 2024, reported individually. Dr. Mehra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of coronary angioplasty and stenting by Dr. Mehra, more than 64% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Mehra, published from 2012 to 2022. 2021 was the busiest year, with 2. The most frequent topics are COVID-19, Hospital Mortality and Percutaneous Coronary Intervention. Dr. Mehra's most frequent co-authors are Abbas Alshami, MD, Laura Jean Davidson, MD and Payam Dehghani, MD.

Dmand AI links Dr. Mehra to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Inferior Wall Myocardial Infarction, ST Elevation Myocardial Infarction and Anterior Wall Myocardial Infarction. Abiomed Inc. sponsors the most, 2.

CMS Open Payments shows 1,010 general payments to Dr. Mehra from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. Janssen Pharmaceuticals, Inc paid the most, $18,282. It also lists 1 research payment totaling $29 in 2023.